FDA Investigator Douglas C Kovacs

Douglas C Kovacs has inspections in 18 countries as of 13 Sep 2023. Douglas C Kovacs has collaborated with a combinined 8201 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
194
Last Inspection Date:
13 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Japan, Hungary, Italy, France, Germany, Netherlands, Ireland, Canada, Switzerland, India, United Kingdom of Great Britain and Northern Ireland, Finland, Portugal, Argentina, Bulgaria, Czechia, Latvia
Co-Investigator(s):
Addam S Reynolds, Ademola O Daramola, Adetutu M Gidado, Alberto A Viciedo, Alicia M Mozzachio, Allen F Hall, Allen Lou, Amatul H Marium, Amy L Singer, Amy M Codella, Amy M Cramer, Amy N Chen, Ana S Cabrera, Anastasia M Shields, Angela E Glenn, Anissa M Vargas, Anita R Michael, Ankur C Patel, Ann Marie Montemurro, Anna Lazar, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony J Donato, Antonio M Hampton, Arsen Karapetyan, Ashar P Parikh, Atul J Agrawal, Azza Talaat, Barbara J Maulfair, Barbara J Maulfar, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Barbara L Rellahan, PhD, Barry Rothman, Bei Yu, Brandi N Mcgrady, Brandy N Lepage, Brenda S Zimmer, PhD, Brett R Havranek, Brian J Davis, Brian M Campbell, Brian P Hendrickson, Brooke K Higgins, Burnell M Henry, Byungja E Marciante, Cara M Minelli, Carl A Anderson, Carl A Huffman, III, Carl A Perez, Cary Greene, Caryn M Mcnab, Cassandra L Abellard, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Charisse K Green, Charles J Chacko, Charles M Edwards, Charles R Cote, RIC, Cheryl A Clausen, Cheryl A Grandinetti, Cheryl Llove Harris, Chiang Syin, PhD, Christina Capacci Daniel, PhD, Christina N Maurino, Christina P Burkhart, Christine M Cerenzio, Christine W Twohy, Christopher R Czajka, Christopher T Middendorf, Colin E Tack, Concepcion Cruz, Jr, Constance Y Fears, Cory Greene, Cynthia F Kleppinger, MD, Cynthia Jim, CSO, Daniel B Arrecis, Daniel Gorski, Daniel J Brown, Daniel J Gorski, Daniel J Grabicki, Daniel J Lahar, Daniel J Min, Darren S Brown, David A Oluwo, David H Smith, David M Beltran, Dawn L Wydner, Deborah A Greco, Deborah B Goffman, Deborah B Nixon, Debra J Bennett, Demitria J Xiradakis, Denise M Visco, Investigator, Dennis Cantellops Paite, Devon Jenkins, Deyaa Shaheen, Dinesh Kumar, Don H Bark, PhD, Dorothy J Denes, Douglas A Campbell, Douglas C Kovace, Douglas C Kovees, Dr. Barbara D Paul, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Edward D Harris, Edwardstine J Reese, Eileen A Liu, Elizabeth P Mayer, Emest F Bizjak, Emmanuel J Ramos, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric L Dong, BS, Eric Rothschild, Erin D Mccaffery, Erin D Mccaffrery, Erin M Miller, Ernie F Bizkaj, Esteban Beltran, Farhana Khan, Francis A Guidry, Frank J Marciniak, Frank Wackes, Freddy Ortiz Colon, Frederick Razzack, Frederick Razzaghi, Gavin T Cua, George J Flynn, George M Ibrahim, George Pyramides, Gerald B Seaborn, Jr, Gianine E Delade, Gianine E Tompkins, Gobiga Vanniyasingam, Guerlain Ulysse, Gwyn G Dickinson, Haitao Li, Hassan Ali, Helen B Ricalde, Helen Verdel, Heriberto Negron Rivera, Himanshu Gupta, PhD, Hitesh R Patel, Ifueko Osemwota, Ivis L Negron, Ivis Lnegron Torres, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James A Lane, James D Hildreth, James R Birkenstamm, Janet A Rajan, Jason M Sluzynski, Javier E Santos, Javier O Vega, Jawaid Hamid, Jay B Shah, Jay T Wong, Jean M Kelahan, Jean M Mulinde, MD, Jeffery B Medwid, PhD, Jeffrey A Sommers, Jeffrey J Ebersole, Jeffrey J, Ebersole, Jennifer D Hollstrom, Jennifer R Johnson, Jessica S Estriplet, Jill M Sooter, Jill Mielziner, Joan A Loreng, Jogy George, John P Mistler, Johnna L Bleem, Joie A Navarrete, Jonathan S Helfgott, Jonee J Mearns, Jorge L Guadalupe, Jose A Cruz, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose M Cayuela, Joseph F Mcginnis, RPh, Joseph R Strelnik, Josh Renzon Ramilo, Joshua P Wireman, Jot R Klena, Joy R Kelna, Joy Rkozlowski Klena, Juanita P Versace, Julie D Bringger, Junho Pak, Justine Tomasso, Karen E D'orazio, Karishma G Gopaul, Karyn M Campbell, Kassa Ayalew, MD, Katherine E Jacobitz, Kathryn E Ogger, Kathy E Craven, Kathy E Noe, Keith M Reilley, Keith M Reilly, Kelley L Clark, Kelli F Dobilas, Kelli F Regenye, Kelli Regente, Kellia N Hicks, Kelly I Anderson, Kenneth H Williams, Kerry A Kurdilla, Kevin A Gonzalez, Kham Phommachanh, Kim Lthomas Cruse, King, Kinh Q Mac, Kinh Qouc Mac, Ko U Min, Krishnaiah Yellela, Kristen D Evans, Kristina Nastovski, Kristy A Zielny, Krystal O Ogunremi, Laishan L Lam, Larry Johnson, Larry K Austin, Lata C Mathew, PhD, Latorie S Jones, Laura Fontan, MS, Lauren E Burke, Lauren E Sexton, Lauren E Skokan, Lauren L Vajo, Lawrence R Johnson, LCDR Debra Emerson, LCDR Michael H Tollon, Leon L Law, Li Li, Liatte Kreuger, PharmD, Liattle Krueger, Linda Thai, Lisa B Hall, Lisa Harlan, Lisa Mathew, Lisa Shin, Loretta Nemchik, Lucas B Leake, Luis A Dasta, Luis M Burgos Medero, Lydia Erosas Marty, Lydia Irosas Marty, Lynda L Perry, PhD, Manhar R Patel, Maotang Xhou, Maotang Zhou, PhD, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret L Bolte, Margaret M Annes, Margaret M Sands, Maria Estrella, Maria Manzoni, PhD, Maria Pkelly Doggett, MBA, Marie Bbuen Bigornia, Marjorie D Schultz, Mark E Parmon, Mark G Peterson, Marvin D Jones, Matt D Suedkamp, Matthew A Spataro, Matthew B Casale, Matthew Sparato, Mayar M Mussa, Megan A Haggerty, Meisha Waters, Melba T Rivera, Melba Trivera Clavell, Melissa A Zuppe, Melissa B Libby, Melissa T Roy, Meredith L Sheridan, Merril E Racke, Meyer J Slobotsky, Michael A Charles, Michael E Maselli, Michael J Verdi, Michael L Casner, Michael R Goga, Michael R Klapal, Michael Serrano, Michele Gottshall, Michele L Forster, PhD, Michele Perry Williams, Miguel A Martinez, Mihaly S Ligmond, Milva E Melendez, Milva E Meléndez, Minh D Phan, Misty D Harvey, Mobin A Tawakkul, Monica M Mcclure, Monika Borkowska, Mra B Kamberem, Mra Davism, Mra M Barbosar, Mra Mcculloughj, Nadeem I Chaudhry, Nancy F Scheraga, Nancy G Schmidt, Nancy L Rolli, Nancy M Espinal, Nancy Roll, Nancy Sheraga, Neal L Adams, Nelson A Rodriguez, Nerizza B Guerin, Nicholas A Violand, Nicholas L Paulin, Nicole A Lloyd, Nicole E Knowlton, Niketa Patel, Nikki S Ramirez, Nina Yang, Niraj Mehta, Omotunde O Osunsanmi, Parul M Patel, Patrice S Hall, Patricia D Stahnke, Patricia H Dlugosz, Patrick C Klotzbuecher, Paul A Bonneau, Paul L Bellamy, Paul L Figarole, Jr, Paul Mouris, Peter C Chow, Peter R Lenahan, Philip F Istafanos, DMV, MS, Prabhu P Raju, Pushpa S Jayasekara, Qin Xu, Ralph H Vocque, Ramon A Hernandez, Raquel Gonzalez Rivera, Rebecca E Dombrowski, Regina T Brown, Richard D Manney, Richard E Needham, Richard H Penta, Richard Jay Tucker, RS, Richard W Thornton, Richard W Thorntton, Robert C Steyert, Robert D Tollefsen, Robert G Ruff, Robert M Barbosa, Robert Sharpnack, Robert W Jennings, Robin P Mathew, Rochelle K Kimmel, Rochelle L Campbell, Rochelle L Cross, Rodney G Raiford, Rodney T Allnutt, Rodrigo Vilchez, Rose Ljean Mary, Roy Baby, Russell J Glapion, Russell K Riley, Sachinkumar V Patel, Saleem A Akhtar, Samir C Gala, Sandra A Boyd, Sandra A Hughes, Sandra Kershaw, Santos E Camara, Sarah Adella Fave, Sarah E Mcmullen, Satheesh K Podaralla, Satheesh Thomas, Schultz, Scott T Ballard, Sena G Dissmeyer, Shahla Parvizi, Sharon K Thoma, PharmD, Shawn E Larson, Sherri J Liu, Sherry G Bous, Shirley H Isbill, Shirley S Wen, Sidney B Priesmeyer, Simone E Pitts, Sinai Davis, Sneha S Patel, Sonia R Peterson, Srinivas R Chennamaneni, PhD, Stephanie T Durso, Stephen D Brown, Stephen J Mottola, Steven A Gonzales, Steven C Madzo, Steven D Kehoe, Steven Fong, MS, PhD, Steven M Weinman, Steven P Donald, Sunita Iyer, Susan M Halsted, Susan M Jackson, Susanna E Ford, Analyst, Susant Hadman, Taichun Qin, PhD, Tamil Arasu, PhD, Tania E Garcia, Tania E Vizcaino, Tara G Bizjak, Tara R Bizjak, Tara R Gooen, Tekalign Wondimu, Temar Q Williams, Teresa I Navas, Terri L Dodds, Theodore N Sietsema, Thomas J Arista, Tonia F Bernard, Tonya R Johnson, Torrance J Slayton, Toyin B Oladimeji, Travis S Bradley, Tressa T Lewis, Tyanna N Hadley, Tynna N Hadley, Unnee Ranjan, Uttaniti Limchumroon (Tom), Valerie C Reed, Valerie L Whipp, Valerie Reed, Vera M Anderson, Veronica Fuentes, MS, Victoria Spivak, Vilmary Negron Rodriguez, Viviana Matta, Vlada Matusovsky, Walden H Lee, Wayne E Seifert, Wayne J Meyer, Wei Wang, PhD, Wendy G Tan, PhD, William J Muszynski, William R Chang, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Xiuju Lu, Yangmin Ning, Yasamin Ameri, Youmin Wang, Yumi J Hiramine, Yvesna C Blaise, Yvins Dezan, Zachary L Miller, Zakaria I Ganiyu, Zhijin Chen

Douglas C Kovacs's Documents

Publish Date Document Type Title
April, 2004 EIR Hikma Pharmaceuticals USA, Inc. - EIR, 2004-04-15
March, 2001 FDA 483 Actavis Elizabeth LLC - Form 483, 2001-03-12
September, 2001 EIR The P.F. Laboratories Inc. - EIR, 2001-09-21
March, 2003 FDA 483 Ivax Pharmaceuticals Inc - Form 483, 2003-03-07
July, 2004 FDA 483 Mead Johnson & Company, LLC - Form 483, 2004-07-23
September, 2005 EIR Eli Lilly And Co. Limited - EIR, 2005-09-15
August, 2013 FDA 483 Response ImprimisRx NJ - Form 483R, 2013-09-03
June, 2004 FDA 483 Response Pliva, Inc. - Form 483R, 2004-06-16
November, 2008 FDA 483 DERMARITE INDUSTRIES, LLC - Form 483, 2008-11-17
June, 2000 FDA 483 Halo Pharmaceutical Inc - Form 483, 2000-06-20
February, 2013 FDA 483 Response Actavis Elizabeth LLC - Form 483R, 2013-03-08
January, 2003 EIR Actavis Elizabeth LLC - EIR, 2003-01-15
June, 2011 FDA 483 Genzyme Corporation - Form 483, 2011-06-21
April, 2003 FDA 483 Penick Corp - Form 483, 2003-04-03
June, 2003 EIR Unigene Laboratories, Inc. - EIR, 2003-06-16
October, 2003 FDA 483 Halo Pharmaceutical Inc - Form 483, 2003-10-24
August, 2012 EIR Novartis Pharmaceuticals Corporation - EIR, 2012-08-23
July, 2003 FDA 483 Response MERCK SERONO SPA - Form 483R, 2003-08-01
August, 2011 FDA 483 Englewood Lab, Inc. - Form 483, 2011-08-25
May, 2001 EIR SGS North America Inc. - EIR, 2001-05-23
May, 2001 FDA 483 Response SGS North America Inc. - Form 483R, 2001-06-15
August, 2003 FDA 483 Response Actavis Totowa LLC - Form 483R, 2003-09-19
February, 2000 EIR Novartis Pharmaceuticals Corporation - EIR, 2000-12-21
March, 2008 EIR Discovery Laboratories Inc. - EIR, 2008-03-25
September, 2002 EIR Ivax Pharmaceuticals Inc - EIR, 2002-09-19
March, 2000 EIR I S P Van Dyk Inc - EIR, 2000-03-09
February, 2008 FDA 483 Hoffmann La Roche Inc - Form 483, 2008-02-05
June, 2000 FDA 483 Response Knoll Pharmaceutical Company - Form 483R, 2000-06-23
December, 2000 FDA 483 Response Reed-Lane, Inc. - Form 483R, 2000-12-21
January, 2002 EIR Abbott Laboratories - EIR, 2002-01-11
October, 2002 FDA 483 Response DMV International - Form 483R, 2002-10-31
November, 2000 FDA 483 Response Novus Fine Chemicals - Form 483R, 2000-12-01
June, 2002 FDA 483 Ivax Pharmaceuticals Inc - Form 483, 2002-06-20
July, 2002 EIR Pliva, Inc. - EIR, 2002-07-26
December, 2007 EIR Ranbaxy, Inc. - EIR, 2007-12-19
October, 2002 EIR DMV International - EIR, 2002-10-17
April, 2000 FDA 483 Response TEVA Pharmaceuticals USA Inc - Form 483R, 2000-05-10
May, 2018 FDA 483 HOVIONE FARMACIENCIA, S.A. - Form 483, 2018-05-18
September, 2003 EIR Ingenus Pharmaceuticals NJ, LLC - EIR, 2003-09-19
April, 2003 EIR Johnson & Johnson Healthcare Products Div. Mcneil-ppc, Inc. - EIR, 2003-04-24
July, 2003 EIR MERCK SERONO SPA - EIR, 2003-07-21
May, 2007 FDA 483 Response Central Admixture Pharmacy Services, Inc. - Form 483R, 2007-06-15
October, 2007 FDA 483 Leading Pharma, LLC - Form 483, 2007-10-23
April, 2000 FDA 483 TEVA Pharmaceuticals USA Inc - Form 483, 2000-04-26
December, 2003 FDA 483 Response Lilly France - Form 483R, 2004-02-18
July, 2003 FDA 483 MERCK SERONO SPA - Form 483, 2003-07-21
November, 2001 EIR Ivax Pharmaceuticals Inc - EIR, 2001-11-29
September, 2001 FDA 483 Response The P.F. Laboratories Inc. - Form 483R, 2001-09-26
June, 2001 EIR Fermion Oy - EIR, 2001-06-21
December, 2005 FDA 483 Merck, Inc. - Form 483, 2005-12-14
October, 2003 FDA 483 Contract Coating Inc. - Form 483, 2003-10-10
February, 2008 EIR Hoffmann La Roche Inc - EIR, 2008-02-05
April, 2003 EIR Penick Corp - EIR, 2003-04-03
January, 2023 FDA 483 Jamol Laboratories, Inc. - Form 483, 2023-01-12
July, 2009 FDA 483 Ingenus Pharmaceuticals NJ, LLC - Form 483, 2009-07-07
February, 2013 EIR Actavis Elizabeth LLC - EIR, 2013-02-15
June, 2000 EIR Halo Pharmaceutical Inc - EIR, 2000-06-20
May, 2001 FDA 483 SGS North America Inc. - Form 483, 2001-05-23
April, 2004 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2004-04-15
June, 2003 FDA 483 Response Unigene Laboratories, Inc. - Form 483R, 2003-06-27
June, 2012 FDA 483 AustarPharma, LLC - Form 483, 2012-06-05
December, 2007 FDA 483 Ranbaxy, Inc. - Form 483, 2007-12-19
September, 2009 FDA 483 MPL Laboratories - Form 483, 2009-09-18
April, 2000 EIR TEVA Pharmaceuticals USA Inc - EIR, 2000-04-26
February, 2011 FDA 483 Hoffmann La Roche Inc - Form 483, 2011-02-04
June, 2000 FDA 483 Response Halo Pharmaceutical Inc - Form 483R, 2000-07-13
June, 2002 FDA 483 Response Ivax Pharmaceuticals Inc - Form 483R, 2002-07-10
March, 2009 FDA 483 Actavis Totowa LLC - Form 483, 2009-03-31
August, 2000 FDA 483 Response Halo Pharmaceutical Inc - Form 483R, 2000-08-29
July, 2003 FDA 483 NPBI International BV - Form 483, 2003-07-11
October, 2003 EIR Contract Coating Inc. - EIR, 2003-10-10
November, 2000 EIR Novus Fine Chemicals - EIR, 2000-11-27
August, 2009 FDA 483 Hoffmann La Roche Inc - Form 483, 2009-08-18
June, 2013 EIR Leading Pharma, LLC - EIR, 2013-06-12
August, 2006 FDA 483 Elite Laboratories, Inc. - Form 483, 2006-08-04
October, 2003 FDA 483 Response Contract Coating Inc. - Form 483R, 2004-01-02
July, 2004 EIR Mead Johnson & Company, LLC - EIR, 2004-07-23
December, 2003 EIR Lilly France - EIR, 2003-12-08
February, 2020 EIR SOLARA ACTIVE PHARMA SCIENCES LIMITED - EIR, 2020-02-21
November, 2000 FDA 483 Novus Fine Chemicals - Form 483, 2000-11-27
January, 2003 FDA 483 Actavis Elizabeth LLC - Form 483, 2003-01-15
July, 2007 EIR Amneal Pharmaceuticals, LLC - EIR, 2007-07-17
February, 2013 FDA 483 Actavis Elizabeth LLC - Form 483, 2013-02-15
September, 2010 EIR Novartis Pharmaceuticals Corporation - EIR, 2010-09-03
October, 2001 FDA 483 Response Watson Pharma, Inc. - Form 483R, 2001-12-03
July, 2004 FDA 483 Response Mead Johnson & Company, LLC - Form 483R, 2004-08-05
September, 2005 FDA 483 Eli Lilly And Co. Limited - Form 483, 2005-09-15
November, 2022 EIR CAMBREX PROFARMACO MILANO SRL - EIR, 2022-12-22
July, 2007 FDA 483 Response Amneal Pharmaceuticals, LLC - Form 483R, 2007-08-07
September, 2003 FDA 483 Ingenus Pharmaceuticals NJ, LLC - Form 483, 2003-09-19
October, 2002 FDA 483 DMV International - Form 483, 2002-10-17
April, 2003 FDA 483 Johnson & Johnson Healthcare Products Div. Mcneil-ppc, Inc. - Form 483, 2003-04-24
July, 2008 FDA 483 Halo Pharmaceutical Inc - Form 483, 2008-07-29
May, 2005 FDA 483 Hoffmann La Roche Inc - Form 483, 2005-05-27
March, 2000 FDA 483 I S P Van Dyk Inc - Form 483, 2000-03-09
June, 2004 FDA 483 Pliva, Inc. - Form 483, 2004-06-02
November, 2000 EIR McNeil PPC Inc. - EIR, 2000-11-08
November, 2001 FDA 483 Ivax Pharmaceuticals Inc - Form 483, 2001-11-29
May, 2003 EIR Baxter Healthcare Corporation - EIR, 2003-05-12
June, 2000 EIR Knoll Pharmaceutical Company - EIR, 2000-06-13
June, 2013 FDA 483 Leading Pharma, LLC - Form 483, 2013-06-12
August, 2013 FDA 483 Novel Laboratories, Inc. - Form 483, 2013-09-11
March, 2012 EIR Teva Pharmaceuticals USA, Inc. - EIR, 2012-03-30
August, 2000 FDA 483 Halo Pharmaceutical Inc - Form 483, 2000-08-04
June, 2004 EIR Pliva, Inc. - EIR, 2004-06-02
December, 2000 FDA 483 Reed-Lane, Inc. - Form 483, 2000-12-15
March, 2001 FDA 483 Response Actavis Elizabeth LLC - Form 483R, 2001-03-23
May, 2009 FDA 483 Pliva, Inc. - Form 483, 2009-05-05
February, 2000 EIR Frutarom USA Inc. - EIR, 2000-02-16
October, 2003 FDA 483 Response Halo Pharmaceutical Inc - Form 483R, 2003-11-05
January, 2005 EIR Aphena Pharma Solutions - EIR, 2005-01-25
June, 2000 FDA 483 Knoll Pharmaceutical Company - Form 483, 2000-06-20
March, 2001 EIR Actavis Elizabeth LLC - EIR, 2001-03-12
May, 2005 FDA 483 Response Hoffmann La Roche Inc - Form 483R, 2005-06-28
August, 2010 FDA 483 Contract Coating Inc. - Form 483, 2010-08-02
July, 2013 EIR JAK Diversified II, Inc. dba Multi-Pak Packaging - EIR, 2013-07-22
August, 2013 FDA 483 ImprimisRx NJ - Form 483, 2013-08-19
October, 2003 EIR Halo Pharmaceutical Inc - EIR, 2003-10-24
March, 2003 EIR Ivax Pharmaceuticals Inc - EIR, 2003-03-07
December, 2010 FDA 483 Unipack LLC - Form 483, 2010-12-08
June, 2003 FDA 483 Unigene Laboratories, Inc. - Form 483, 2003-06-16
May, 2005 EIR Hoffmann La Roche Inc - EIR, 2005-05-27
February, 2003 EIR Sharp Corporation - EIR, 2003-02-21
February, 2000 EIR McNeil PPC Inc. - EIR, 2000-02-09
May, 2007 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2007-05-08
August, 2000 EIR Halo Pharmaceutical Inc - EIR, 2000-08-04
August, 2003 FDA 483 Actavis Totowa LLC - Form 483, 2003-08-21
October, 2001 FDA 483 Watson Pharma, Inc. - Form 483, 2001-10-30
September, 2002 EIR Barr Laboratories, Inc. - EIR, 2002-09-06
May, 2008 FDA 483 Actavis Elizabeth LLC - Form 483, 2008-05-21
June, 2002 EIR Ivax Pharmaceuticals Inc - EIR, 2002-06-20
December, 2000 EIR Reed-Lane, Inc. - EIR, 2000-12-15
April, 2003 FDA 483 Response Penick Corp - Form 483R, 2003-04-10
August, 2003 EIR Actavis Totowa LLC - EIR, 2003-08-21
September, 2001 FDA 483 The P.F. Laboratories Inc. - Form 483, 2001-09-21
July, 2007 FDA 483 Amneal Pharmaceuticals, LLC - Form 483, 2007-07-17
January, 2002 EIR Merck Sharp & Dohme LLC - EIR, 2002-01-28
May, 2018 EIR HOVIONE FARMACIENCIA, S.A. - EIR, 2018-05-18

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more